Market Access of Nintedanib for Idiopathic Pulmonary Fibrosis- A Cross-Country Review of Access Conditions
Oct 1, 2017, 00:00 AM
10.1016/j.jval.2017.08.951
https://www.valueinhealthjournal.com/article/S1098-3015(17)31285-8/fulltext
Section Title :
Disease-Specific Studies
Section Order :
906
First Page :
A566
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(17)31285-8&doi=10.1016/j.jval.2017.08.951